The Consolidated Appropriations Act of 2026 gives CMS more leverage to intercept when pharmacy benefit managers are driving up prices in Medicare Part D, explains Jesse Dresser, Esq.
Pharmacy leaders should watch Medicare MFP as it changes Part D drug pricing and introduces new reconciliation challenges for ...
AbbVie sues HHS over Botox Medicare pricing, challenging CMS authority under the Inflation Reduction Act and drug price negotiation rules.
News-Medical.Net on MSN
Three PBMs dominate retail prescriptions in Medicare Part D and Medicaid markets
Just three pharmacy benefit managers (PBM) dominate retail prescriptions in Medicare Part D and Medicaid managed care across ...
Congress passed a bipartisan spending package on Feb. 3 that carries ramifications for telehealth, pharmacy benefit managers, ...
OVERLAND PARK, Kan., Dec. 2, 2025 /PRNewswire/ -- Quest Analytics, the leader in provider network design and management solutions, announced today that the Centers for Medicare & Medicaid Services ...
The Centers for Medicare and Medicaid Services has issued a proposed rule to drive down prescription drug costs in Medicaid by increasing price transparency. The rule would allow CMS to have more ...
WASHINGTON — Describing cuts to Medicaid reimbursement as “devastating” to retail pharmacies, Dennis Wiesner, senior director of privacy, regulatory, government and industry affairs, and pharmacy ...
Sen. Lankford applauds passage of bipartisan legislation he says will help lower drug prices and also help keep pharmacies in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results